Medical Advocates
Zidovudine/Lamivudine (Combivir)
 
Main Page

New and Noteworthy
Database of ARV Drug Interactions
Combivir PI
Journal Data
 Conference Data
 Pediatric Data
 Perinatal Data

 
ARV Main Page Main New/Newsworthy Home Page      
Last updated:  June 10, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     
June  2008
 
Drug Alerts
 
Pediatric Data
       
USPHS Pediatric Antiretroviral Drug Information

 US Treatment Guidelines
 
Efficacy
 
ZDV/3TC vs DDI

    Journal Papers, Abstracts, and Commentaries

  A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy
in children with symptomatic therapy-naïve HIV-1 infection.
The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team.
McKinney RE,Johnson GM, Stanley K et al.
Journal of Pediatrics 1998; 133(4): 500-508.
Abstract
   
  Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected
children.
AIDS Clinical Trials Group (ACTG) Study 152 Team. 
Englund JA, Baker CJ, Raskino C et al.
New England Journal of Medicine 1997; 336(24): 1704-1712.
Abstract

ZDV/3TC/ABC vs ZDV/ 3TC

     Journal Papers, Abstracts, and Commentaries

  A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine,
and zidovudine versus lamivudine and zidovudine in previously treated human
immunodeficiency virus type 1-infected children.
Saez-Llorens X, Nelson RP, Emmanuel P et al
Pediatrics. 2001 Jan;107(1):E4.
 Abstract

  

ARV Main Page Main New/Newsworthy Home Page      

Combivir Main Page